Investor Protection

Business

Arcturus Therapeutics: Market Skepticism Paints a Zero-Success Picture for Pipeline, But Analysts See Deep Value

Despite promising mid-stage clinical data and billion-dollar sales potential for its mRNA pipeline, Arcturus Therapeutics (ARCT) is trading near its cash value—a signal the market is assigning near-zero odds to its success. This stark disconnect has analysts debating whether the biotech firm is a glaring mispricing or a high-risk bet.

Feb 2, 2026

Business

Analysts Split on Advance Auto Parts as Hedge Funds Maintain Bullish Stance

Advance Auto Parts (NYSE:AAP) remains a favored pick among hedge funds, even as Wall Street analysts offer conflicting price targets and ratings ahead of anticipated 2026 demand growth.

Feb 2, 2026

Business

Analysts Remain Bullish on Visteon Despite Price Target Trims, Citing Strong Auto Tech Demand

Goldman Sachs and Baird reaffirm positive ratings on automotive technology supplier Visteon (VC), seeing significant upside potential even after modestly lowering price targets, driven by favorable sector outlook and growth in digital cockpit solutions.

Feb 2, 2026

Business

The Hidden Cost of Waiting: How Federal Debt Collection Can Undermine Delayed Social Security Claims

A common retirement strategy—delaying Social Security to maximize benefits—can have an unintended consequence for millions: significantly larger garnishments for federal debts. As the Treasury withholds percentages, not fixed sums, a bigger monthly check means a bigger automatic deduction.

Feb 2, 2026

Business

Disney's Leadership Crossroads: Can New CEO Navigate a Shifting Media Landscape?

As Bob Iger steps aside, incoming CEO Josh D'Amaro inherits a media giant facing stagnant growth, a challenged streaming division, and intense sector consolidation. Analysts debate whether a strategic overhaul or a potential sale offers the best path forward for the House of Mouse.

Feb 2, 2026

Business

MicroStrategy Adds $75M in Bitcoin Ahead of Market Dip, Holding Steady at 713,502 BTC

The business intelligence firm, led by Michael Saylor, continued its Bitcoin acquisition strategy with a modest $75.3 million purchase last week, bringing its total holdings to 713,502 BTC. Despite a recent price correction, the company's average purchase price remains below current market levels.

Feb 2, 2026

US

Repeat Offender in Arizona Border Shooting Incident Had History of Confrontations with Authorities

A suspected human smuggler with a prior conviction was shot by federal agents near the Arizona-Mexico border after allegedly firing at a CBP helicopter and agents during a foot pursuit, according to law enforcement officials.

Feb 2, 2026

US

Government Funding Deadline Looms as House Returns Amid ICE Controversy

Congress faces a critical vote to avert a prolonged shutdown, while newly released documents shed light on the Minneapolis shooting involving immigration officers and the Epstein case continues to reverberate.

Feb 2, 2026

US

Classified Whistleblower Complaint Against Intel Chief Gabbard Stalled for Eight Months, Sparking Transparency Concerns

A highly sensitive whistleblower complaint alleging misconduct by Director of National Intelligence Tulsi Gabbard has been locked within the intelligence bureaucracy since May, with Congress aware of its existence but blocked from reviewing it amid accusations of obstruction.

Feb 2, 2026

Business

Garrett Motion Gains Analyst Favor as Zero-Emission Tech Fuels Growth Outlook

Garrett Motion (GTX) is drawing strong buy ratings from analysts, with a median price target suggesting over 20% upside, driven by its strategic pivot to zero-emission vehicle technologies and resilient financial profile.

Feb 2, 2026

Business

Lexeo Therapeutics Faces Market Skepticism Despite Positive PKP2 Gene Therapy Data

H.C. Wainwright maintains a Buy rating on Lexeo Therapeutics but slashes its price target, citing persistent market doubts over the company's PKP2 cardiomyopathy program despite encouraging early clinical results.

Feb 2, 2026

Business

Goodyear Poised for Growth as Replacement Tire Market Gains Momentum

Analysts maintain a bullish outlook on Goodyear Tire & Rubber, citing strong potential in the replacement tire market and favorable inventory trends, with a median price target suggesting a 7% upside.

Feb 2, 2026

Business

Aptiv Gains Analyst Favor as Strategic Shift Yields 'More Realistic' Growth Outlook

Aptiv PLC sees mixed but upwardly revised price targets from major analysts, with Piper Sandler upgrading the auto tech supplier to Overweight and naming it a top pick for 2026, citing its pragmatic strategy and attractive valuation.

Feb 2, 2026

Business

Mobileye Eyes 2026 as Pivotal Year Amid Analyst Backing and Strategic Shifts

Despite recent guidance revisions, Mobileye Global retains strong buy ratings from analysts who see significant upside potential, as the company positions 2026 for a strategic transition in the autonomous driving sector.

Feb 2, 2026

Business

AutoZone Revs Up Expansion Plans as Analysts Debate Outlook Amid Sales Pressure

Despite a recent sales miss, AutoZone (AZO) is doubling down on store growth, drawing mixed analyst reactions. JPMorgan remains bullish with an $4,100 price target, while Wolfe Research downgraded the stock, highlighting the complex landscape for the auto parts retailer.

Feb 2, 2026

Business

Barclays Bullish on 4D Molecular Therapeutics, Sees M&A and Pricing Trends as Key Catalysts

Barclays initiates coverage of 4D Molecular Therapeutics with an Overweight rating and a $33 price target, citing a favorable industry backdrop with potential M&A tailwinds and shifting focus away from drug pricing pressures. The gene therapy developer also outlined key clinical milestones expected through 2026.

Feb 2, 2026

Business

Korro Bio's KRRO-121 Emerges as Independent Value Driver, Sparking Analyst Upgrades

H.C. Wainwright and Chardan Capital upgrade Korro Bio (KRRO) to Buy, citing the independent potential of its RNA-editing asset KRRO-121 and strong preclinical data as key catalysts.

Feb 2, 2026

Business

Disney's Sora-Generated Shorts to Debut on Disney+, But Iger Insists Core Slate Unaffected

Disney CEO Bob Iger confirmed that AI-generated videos from OpenAI's Sora will begin appearing on Disney+ within months, framing the move as an additive feature for short-form content while downplaying any ripple effects on the company's traditional film and TV pipeline.

Feb 2, 2026

Business

Google Integrates Gemini AI Deeper Into Chrome, Reshaping the Browser Experience

Google is rolling out a significant update to its Chrome browser, embedding advanced Gemini AI capabilities directly into the user interface. The move signals a strategic push to make AI a central, everyday tool for web navigation and tasks.

Feb 2, 2026

Business

Alibaba's Cainiao to Invest $2 Billion in Autonomous Trucking Startup Zelos Technology

Alibaba's logistics arm Cainiao is making a major strategic move into autonomous freight, with a reported $2 billion investment in L4 self-driving truck firm Zelos Technology, signaling a deepening push into AI-driven supply chain solutions.

Feb 2, 2026